Lori A. Coburn
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Lori A. Coburn has a total of 364 co-authors. Here are the top co-authors by number of shared publications:
- Keith T. Wilson
Division of Gastroenterology, Hepatology, and Nutrition, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA
49 shared publications - Margaret M. Allaman
Division of Gastroenterology, Hepatology, and Nutrition, Department of Medicine, Vanderbilt University Medical Center, Nashville, USA
23 shared publications - Christopher S. Williams
Department of Medicine, Division of Gastroenterology, Vanderbilt University Medical Center, Nashville, Tennessee, USA
20 shared publications Kshipra Singh
Division of Gastroenterology, Hepatology, and Nutrition, Department of Medicine, Vanderbilt University Medical Center, Nashville, USA
19 shared publicationsM. Kay Washington
Program in Chemical and Physical Biology, Vanderbilt University School of Medicine, Nashville, USA
15 shared publicationsMohammad Asim
Division of Gastroenterology, Hepatology, and Nutrition, Department of Medicine, USA
15 shared publications
Latest Publications
- Open Access
Facilitating Valid Statistical Inference in Biomedical Image Synthesis
Generative AI for medical image synthesis is increasingly used to impute missing data and augment biomedical datasets. Yet despite achieving high computational similarity to their real-world counterparts, synthetic images remain uncommon in clinical research practice, in part because of concerns about their biological validity. Here, we evaluate whether synthetic images support reliable downstream statistical analysis and biological inference in magnetic resonance imaging (MRI) and multiplexed immunofluorescence (mIF) imaging. We find that associations between patient phenotypes and synthesized images can be severely attenuated. This is because synthesis methods typically omit clinically relevant covariates and therefore generate images that, although visually realistic, mask key biological differences. Furthermore, naive analyses treat synthesized images as if they were observed, ignoring the statistical uncertainty introduced by synthesis. Drawing on multiple imputation theory, we introduce Phenotype Aware Multiple Synthesis (PAMS), an analysis framework that requires no model retraining and instead adjusts synthesized output to recover valid biological estimates with appropriately calibrated uncertainty. Applied to MRI and mIF data, PAMS reduced estimation bias and restored nominal confidence interval coverage. Because it is compatible with existing synthesis pipelines, PAMS offers a practical and rigorous route to statistically and biologically valid use of synthesized images in biomedical imaging research.
Open AccessFacilitating Valid Statistical Inference in Biomedical Image Synthesis
Generative AI for medical image synthesis is increasingly used to impute missing data and augment biomedical datasets. Yet despite achieving high computational similarity to their real-world counterparts, synthetic images remain uncommon in clinical research practice, in part because of concerns about their biological validity. Here, we evaluate whether synthetic images support reliable downstream statistical analysis and biological inference in magnetic resonance imaging (MRI) and multiplexed immunofluorescence (mIF) imaging. We find that associations between patient phenotypes and synthesized images can be severely attenuated. This is because synthesis methods typically omit clinically relevant covariates and therefore generate images that, although visually realistic, mask key biological differences. Furthermore, naive analyses treat synthesized images as if they were observed, ignoring the statistical uncertainty introduced by synthesis. Drawing on multiple imputation theory, we introduce Phenotype Aware Multiple Synthesis (PAMS), an analysis framework that requires no model retraining and instead adjusts synthesized output to recover valid biological estimates with appropriately calibrated uncertainty. Applied to MRI and mIF data, PAMS reduced estimation bias and restored nominal confidence interval coverage. Because it is compatible with existing synthesis pipelines, PAMS offers a practical and rigorous route to statistically and biologically valid use of synthesized images in biomedical imaging research.
- Open Access
- 15 June 2026
- Published by Elsevier in Cancer Letters
- Vol. 656, 218682
Regulation of EIF5A and hypusination by p53 determines colorectal cancer cell fitness
- 15 June 2026
- Published by Elsevier in Cancer Letters
- Vol. 656, 218682
Open AccessRegulation of EIF5A and hypusination by p53 determines colorectal cancer cell fitness
- Open Access
- 9 March 2026
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
Non-invasive determination of disease activity in Crohn’s disease by serum luminex profiling
Crohn’s disease (CD) is a type of inflammatory bowel disease (IBD), and treatment depends on disease activity assessment requiring invasive procedures. We aimed to identify serum cytokines/chemokines that differ between CD and controls, and by clinical, endoscopic, and histologic disease activity. Serum samples were obtained from 103 CD to 40 non-IBD controls undergoing colonoscopy. Clinical information was obtained by questionnaire and chart review. Disease activity was determined: clinically (Crohn’s Disease Activity Index), endoscopically (Simple Endoscopic Score for Crohn’s Disease), and histologically from colonoscopic biopsies. Cytokines/chemokines were measured by Luminex assay and compared by disease activity assessments (control vs. inactive vs. active), with adjustment for multiple comparisons. Correlation between activity indices and versus analytes were performed. Multiple analytes were significantly altered between clinically, endoscopically, and histologically inactive and active CD vs. control. One analyte, CXCL9, was significantly increased in active vs. inactive CD in endoscopic and histologic activity assessments. CXCL9 was the only analyte with a significant correlation to both SES ( r = 0.57, q < 0.001) and histologic severity ( r = 0.42, q < 0.001). CXCL9 had the highest discriminatory capacity for active vs. inactive disease both endoscopically (AUC = 0.76, 95% CI 0.65–0.87) and histologically (AUC = 0.79, 95% CI 0.70–0.88). Cytokine/chemokine profiling differentiated CD vs. controls and by disease activity, with CXCL9 as a potential marker distinguishing activity in endoscopic and histologic assessments. Serum cytokine/chemokine profiling may be a non-invasive strategy to assess disease activity in CD.
- 9 March 2026
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
Open AccessNon-invasive determination of disease activity in Crohn’s disease by serum luminex profiling
Crohn’s disease (CD) is a type of inflammatory bowel disease (IBD), and treatment depends on disease activity assessment requiring invasive procedures. We aimed to identify serum cytokines/chemokines that differ between CD and controls, and by clinical, endoscopic, and histologic disease activity. Serum samples were obtained from 103 CD to 40 non-IBD controls undergoing colonoscopy. Clinical information was obtained by questionnaire and chart review. Disease activity was determined: clinically (Crohn’s Disease Activity Index), endoscopically (Simple Endoscopic Score for Crohn’s Disease), and histologically from colonoscopic biopsies. Cytokines/chemokines were measured by Luminex assay and compared by disease activity assessments (control vs. inactive vs. active), with adjustment for multiple comparisons. Correlation between activity indices and versus analytes were performed. Multiple analytes were significantly altered between clinically, endoscopically, and histologically inactive and active CD vs. control. One analyte, CXCL9, was significantly increased in active vs. inactive CD in endoscopic and histologic activity assessments. CXCL9 was the only analyte with a significant correlation to both SES ( r = 0.57, q < 0.001) and histologic severity ( r = 0.42, q < 0.001). CXCL9 had the highest discriminatory capacity for active vs. inactive disease both endoscopically (AUC = 0.76, 95% CI 0.65–0.87) and histologically (AUC = 0.79, 95% CI 0.70–0.88). Cytokine/chemokine profiling differentiated CD vs. controls and by disease activity, with CXCL9 as a potential marker distinguishing activity in endoscopic and histologic assessments. Serum cytokine/chemokine profiling may be a non-invasive strategy to assess disease activity in CD.
- Open Access
- 17 February 2026
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 136 (7)
Pathobiont-triggered induction of goblet cell response drives regional susceptibility to inflammatory bowel disease
The gastrointestinal tract varies in structure and function by region, yet the drivers of region-specific inflammatory disease remain elusive. Here, a TNF-overexpressing murine model ( Tnf ΔARE/+ ) of Crohn’s disease (CD) was used to investigate how pathobionts interact with host immune susceptibilities to drive region-specific disease. We identified the pathobiont Chlamydia muridarum , an intracellular bacterium and murine counterpart to the human sexually transmitted C . trachomatis , as a necessary and sufficient trigger for disease manifestation in the proximal/ascending colon, a common site of CD. In genetically susceptible hosts, pathobiont-triggered proximal colonic inflammation is driven by goblet cell responses, including tryptophan metabolism via indoleamine 2,3-dioxygenase 1 (IDO1). Our findings translate to human disease, where we demonstrate upregulation of epithelia-derived IDO1 in actively inflamed ascending colon specimens, but not actively inflamed terminal ileum specimens, of patients with CD. Our findings mechanistically reveal how genetic and microbial factors drive the manifestation of disease in a region-specific manner and provide a unique model to study CD specific to the ascending colon.
- 17 February 2026
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 136 (7)
Open AccessPathobiont-triggered induction of goblet cell response drives regional susceptibility to inflammatory bowel disease
The gastrointestinal tract varies in structure and function by region, yet the drivers of region-specific inflammatory disease remain elusive. Here, a TNF-overexpressing murine model ( Tnf ΔARE/+ ) of Crohn’s disease (CD) was used to investigate how pathobionts interact with host immune susceptibilities to drive region-specific disease. We identified the pathobiont Chlamydia muridarum , an intracellular bacterium and murine counterpart to the human sexually transmitted C . trachomatis , as a necessary and sufficient trigger for disease manifestation in the proximal/ascending colon, a common site of CD. In genetically susceptible hosts, pathobiont-triggered proximal colonic inflammation is driven by goblet cell responses, including tryptophan metabolism via indoleamine 2,3-dioxygenase 1 (IDO1). Our findings translate to human disease, where we demonstrate upregulation of epithelia-derived IDO1 in actively inflamed ascending colon specimens, but not actively inflamed terminal ileum specimens, of patients with CD. Our findings mechanistically reveal how genetic and microbial factors drive the manifestation of disease in a region-specific manner and provide a unique model to study CD specific to the ascending colon.
- Open Access
- 12 December 2024
- Published by JMIR Publications Inc. in JMIR Formative Research
- Vol. 9, e70016
Enhancing Clinical Data Management through Barcode Integration and REDCap: Innovations in Scalability and Adaptability (Preprint)
Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet #Preprint #PeerReviewMe: Warning: This is a unreviewed preprint. Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn. Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period. Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author). Background: Effective data management is crucial in clinical studies for precise tracking, secure storage, and reliable analysis of samples. Traditional systems often encounter challenges like barcode recognition errors, inadequate data detail, and diminished performance under heavy workloads. Objective: This paper aims to enhance clinical data management by improving barcode robustness, increasing data granularity, and boosting system throughput. These improvements address key challenges in barcode informatics systems, as highlighted in prior studies, to better support real clinical applications. Additionally, we aim to validate the design criteria on various gastrointestinal (GI) related studies, ensuring it can be easily integrated into other clinical data management workflows. Methods: We evaluated the robustness of various barcode technologies under significant blurring conditions, implemented a dynamic organ-specific archive in the REDCap database for various clinical study data collection criteria, and utilized Docker to containerize the informatics software for different studies. Additionally, we proposed a local cache system to reduce interaction times with REDCap for large-scale data records. Experimental setups include assessing barcode recognition accuracy under various levels of image blurring, showcasing different study types managed with the organ-specific archive, and measuring system throughput and response times with and without the proposed local cache system. Results: Our findings demonstrate that the DataMatrix barcode exhibits superior resilience, maintaining high recognition accuracy under blurred conditions. The dynamic organ-specific archive in REDCap enabled precise tracking of sample origins, improving data granularity. Docker containerization streamlines software deployment and ensures consistency across studies. The local cache system significantly reduces interaction times with REDCap, decreasing operating time by nearly eightfold compared to the naïve strategy when handling large patient datasets. Conclusions: The proposed enhancements significantly improve barcode robustness, data granularity, and system throughput in the informatics system, addressing key limitations identified in previous studies. These optimizations ensure efficient data management and robust support for diverse clinical research needs. Clinical Trial: Combinatorial Single Cell Strategies for a Crohn's Disease Gut Cell Atlas (NCT04113733, https://clinicaltrials.gov/study/NCT04113733?cond=NCT04113733&rank=1&tab=table) BCCMA: Targeting Gut-Microbiome in Veterans Deployment Related Gastrointestinal and Liver Diseases: Dysbiosis, PTSD, and Epithelial and Immune Biology in Inflammatory Bowel Disease in Veterans (I01CX002473-01A2, https://research.va.gov/about/funded_research/proj-details-FY2024.cfm?pid=759730) Dysregulated Polyamine Metabolism in H. pylori-associated Gastric Inflammation and Disease Progression (I01CX002171-01, https://research.va.gov/about/funded_research/proj-details-FY2024.cfm?pid=759730) The Role of CCL11 in Inflammatory and Sporadic Colorectal Cancer. (I01CX002662-01A2, https://www.research.va.gov/about/funded_research/proj-details-FY2025.cfm?pid=802842) CCL11 as a New Therapeutic Target for Colitis and Colon Cancer (I01BX004366-01A2, https://research.va.gov/about/funded_research/proj-details-FY2024.cfm?pid=636361)
- 12 December 2024
- Published by JMIR Publications Inc. in JMIR Formative Research
- Vol. 9, e70016
Open AccessEnhancing Clinical Data Management through Barcode Integration and REDCap: Innovations in Scalability and Adaptability (Preprint)
Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet #Preprint #PeerReviewMe: Warning: This is a unreviewed preprint. Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn. Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period. Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author). Background: Effective data management is crucial in clinical studies for precise tracking, secure storage, and reliable analysis of samples. Traditional systems often encounter challenges like barcode recognition errors, inadequate data detail, and diminished performance under heavy workloads. Objective: This paper aims to enhance clinical data management by improving barcode robustness, increasing data granularity, and boosting system throughput. These improvements address key challenges in barcode informatics systems, as highlighted in prior studies, to better support real clinical applications. Additionally, we aim to validate the design criteria on various gastrointestinal (GI) related studies, ensuring it can be easily integrated into other clinical data management workflows. Methods: We evaluated the robustness of various barcode technologies under significant blurring conditions, implemented a dynamic organ-specific archive in the REDCap database for various clinical study data collection criteria, and utilized Docker to containerize the informatics software for different studies. Additionally, we proposed a local cache system to reduce interaction times with REDCap for large-scale data records. Experimental setups include assessing barcode recognition accuracy under various levels of image blurring, showcasing different study types managed with the organ-specific archive, and measuring system throughput and response times with and without the proposed local cache system. Results: Our findings demonstrate that the DataMatrix barcode exhibits superior resilience, maintaining high recognition accuracy under blurred conditions. The dynamic organ-specific archive in REDCap enabled precise tracking of sample origins, improving data granularity. Docker containerization streamlines software deployment and ensures consistency across studies. The local cache system significantly reduces interaction times with REDCap, decreasing operating time by nearly eightfold compared to the naïve strategy when handling large patient datasets. Conclusions: The proposed enhancements significantly improve barcode robustness, data granularity, and system throughput in the informatics system, addressing key limitations identified in previous studies. These optimizations ensure efficient data management and robust support for diverse clinical research needs. Clinical Trial: Combinatorial Single Cell Strategies for a Crohn's Disease Gut Cell Atlas (NCT04113733, https://clinicaltrials.gov/study/NCT04113733?cond=NCT04113733&rank=1&tab=table) BCCMA: Targeting Gut-Microbiome in Veterans Deployment Related Gastrointestinal and Liver Diseases: Dysbiosis, PTSD, and Epithelial and Immune Biology in Inflammatory Bowel Disease in Veterans (I01CX002473-01A2, https://research.va.gov/about/funded_research/proj-details-FY2024.cfm?pid=759730) Dysregulated Polyamine Metabolism in H. pylori-associated Gastric Inflammation and Disease Progression (I01CX002171-01, https://research.va.gov/about/funded_research/proj-details-FY2024.cfm?pid=759730) The Role of CCL11 in Inflammatory and Sporadic Colorectal Cancer. (I01CX002662-01A2, https://www.research.va.gov/about/funded_research/proj-details-FY2025.cfm?pid=802842) CCL11 as a New Therapeutic Target for Colitis and Colon Cancer (I01BX004366-01A2, https://research.va.gov/about/funded_research/proj-details-FY2024.cfm?pid=636361)
- Open Access
- 10 November 2024
- Published by Springer Nature in Oncogene
- Vol. 44 (5) , 296-306
Spermine oxidase promotes Helicobacter pylori-mediated gastric carcinogenesis through acrolein production
Helicobacter pylori is the primary cause of gastric cancer, and there is a need to discover new molecular targets for therapeutic intervention in H. pylori disease progression. We have previously shown that spermine oxidase (SMOX), the enzyme that catabolizes the back-conversion of the polyamine spermine to spermidine, is upregulated during infection and is associated with increased cancer risk in humans. We sought to determine the direct role of SMOX in gastric carcinogenesis during H. pylori infection. In this study, we demonstrate that transgenic FVB/N insulin-gastrin (INS-GAS) mice that develop gastric carcinoma with H. pylori infection were protected from cancer development with Smox deletion. RNA sequencing revealed that genes associated with the immune system and cancer were downregulated in the infected Smox –/– mice. Furthermore, there was a decrease in cell proliferation and DNA damage in infected Smox –/– animals. There was significant generation of adducts of the highly reactive electrophile acrolein, a byproduct of SMOX activity, in gastric tissues from H. pylori-infected humans and wild-type, but not Smox –/– mice. Genetic deletion of Smox in murine organoids or chemical inhibition of SMOX in human gastric epithelial cells significantly reduced generation of acrolein induced by H. pylori. Additionally, acrolein-induced DNA damage in gastric epithelial cells was ablated with the electrophile scavenger 2-hydroxybenzylamine (2-HOBA). Gastric acrolein adduct levels were attenuated in infected INS-GAS mice treated with 2-HOBA, which exhibit reduced gastric carcinoma. These findings implicate SMOX and acrolein in H. pylori-induced carcinogenesis, thus indicating their potential as therapeutic targets.
- 10 November 2024
- Published by Springer Nature in Oncogene
- Vol. 44 (5) , 296-306
Open AccessSpermine oxidase promotes Helicobacter pylori-mediated gastric carcinogenesis through acrolein production
Helicobacter pylori is the primary cause of gastric cancer, and there is a need to discover new molecular targets for therapeutic intervention in H. pylori disease progression. We have previously shown that spermine oxidase (SMOX), the enzyme that catabolizes the back-conversion of the polyamine spermine to spermidine, is upregulated during infection and is associated with increased cancer risk in humans. We sought to determine the direct role of SMOX in gastric carcinogenesis during H. pylori infection. In this study, we demonstrate that transgenic FVB/N insulin-gastrin (INS-GAS) mice that develop gastric carcinoma with H. pylori infection were protected from cancer development with Smox deletion. RNA sequencing revealed that genes associated with the immune system and cancer were downregulated in the infected Smox –/– mice. Furthermore, there was a decrease in cell proliferation and DNA damage in infected Smox –/– animals. There was significant generation of adducts of the highly reactive electrophile acrolein, a byproduct of SMOX activity, in gastric tissues from H. pylori-infected humans and wild-type, but not Smox –/– mice. Genetic deletion of Smox in murine organoids or chemical inhibition of SMOX in human gastric epithelial cells significantly reduced generation of acrolein induced by H. pylori. Additionally, acrolein-induced DNA damage in gastric epithelial cells was ablated with the electrophile scavenger 2-hydroxybenzylamine (2-HOBA). Gastric acrolein adduct levels were attenuated in infected INS-GAS mice treated with 2-HOBA, which exhibit reduced gastric carcinoma. These findings implicate SMOX and acrolein in H. pylori-induced carcinogenesis, thus indicating their potential as therapeutic targets.
- Open Access
- 1 November 2024
- Published by SPIE-Intl Soc Optical Eng in Journal of Medical Imaging
- Vol. 11 (06) , 1-17
Data-driven nucleus subclassification on colon hematoxylin and eosin using style-transferred digital pathology
PurposeCells are building blocks for human physiology; consequently, understanding the way cells communicate, co-locate, and interrelate is essential to furthering our understanding of how the body functions in both health and disease. Hematoxylin and eosin (H&E) is the standard stain used in histological analysis of tissues in both clinical and research settings. Although H&E is ubiquitous and reveals tissue microanatomy, the classification and mapping of cell subtypes often require the use of specialized stains. The recent CoNIC Challenge focused on artificial intelligence classification of six types of cells on colon H&E but was unable to classify epithelial subtypes (progenitor, enteroendocrine, goblet), lymphocyte subtypes (B, helper T, cytotoxic T), and connective subtypes (fibroblasts). We propose to use inter-modality learning to label previously un-labelable cell types on H&E.ApproachWe took advantage of the cell classification information inherent in multiplexed immunofluorescence (MxIF) histology to create cell-level annotations for 14 subclasses. Then, we performed style transfer on the MxIF to synthesize realistic virtual H&E. We assessed the efficacy of a supervised learning scheme using the virtual H&E and 14 subclass labels. We evaluated our model on virtual H&E and real H&E.ResultsOn virtual H&E, we were able to classify helper T cells and epithelial progenitors with positive predictive values of 0.34±0.15 (prevalence 0.03±0.01) and 0.47±0.1 (prevalence 0.07±0.02), respectively, when using ground truth centroid information. On real H&E, we needed to compute bounded metrics instead of direct metrics because our fine-grained virtual H&E predicted classes had to be matched to the closest available parent classes in the coarser labels from the real H&E dataset. For the real H&E, we could classify bounded metrics for the helper T cells and epithelial progenitors with upper bound positive predictive values of 0.43±0.03 (parent class prevalence 0.21) and 0.94±0.02 (parent class prevalence 0.49) when using ground truth centroid information.ConclusionsThis is the first work to provide cell type classification for helper T and epithelial progenitor nuclei on H&E.
- 1 November 2024
- Published by SPIE-Intl Soc Optical Eng in Journal of Medical Imaging
- Vol. 11 (06) , 1-17
Open AccessData-driven nucleus subclassification on colon hematoxylin and eosin using style-transferred digital pathology
PurposeCells are building blocks for human physiology; consequently, understanding the way cells communicate, co-locate, and interrelate is essential to furthering our understanding of how the body functions in both health and disease. Hematoxylin and eosin (H&E) is the standard stain used in histological analysis of tissues in both clinical and research settings. Although H&E is ubiquitous and reveals tissue microanatomy, the classification and mapping of cell subtypes often require the use of specialized stains. The recent CoNIC Challenge focused on artificial intelligence classification of six types of cells on colon H&E but was unable to classify epithelial subtypes (progenitor, enteroendocrine, goblet), lymphocyte subtypes (B, helper T, cytotoxic T), and connective subtypes (fibroblasts). We propose to use inter-modality learning to label previously un-labelable cell types on H&E.ApproachWe took advantage of the cell classification information inherent in multiplexed immunofluorescence (MxIF) histology to create cell-level annotations for 14 subclasses. Then, we performed style transfer on the MxIF to synthesize realistic virtual H&E. We assessed the efficacy of a supervised learning scheme using the virtual H&E and 14 subclass labels. We evaluated our model on virtual H&E and real H&E.ResultsOn virtual H&E, we were able to classify helper T cells and epithelial progenitors with positive predictive values of 0.34±0.15 (prevalence 0.03±0.01) and 0.47±0.1 (prevalence 0.07±0.02), respectively, when using ground truth centroid information. On real H&E, we needed to compute bounded metrics instead of direct metrics because our fine-grained virtual H&E predicted classes had to be matched to the closest available parent classes in the coarser labels from the real H&E dataset. For the real H&E, we could classify bounded metrics for the helper T cells and epithelial progenitors with upper bound positive predictive values of 0.43±0.03 (parent class prevalence 0.21) and 0.94±0.02 (parent class prevalence 0.49) when using ground truth centroid information.ConclusionsThis is the first work to provide cell type classification for helper T and epithelial progenitor nuclei on H&E.
- Open Access
- 22 August 2024
- Published by Springer Nature in Nature Communications
- Vol. 15 (1) , 1-19
Identification and multimodal characterization of a specialized epithelial cell type associated with Crohn’s disease
Crohn’s disease (CD) is a complex chronic inflammatory disorder with both gastrointestinal and extra-intestinal manifestations associated immune dysregulation. Analyzing 202,359 cells from 170 specimens across 83 patients, we identify a distinct epithelial cell type in both terminal ileum and ascending colon (hereon as ‘LND’) with high expression of LCN2, NOS2, and DUOX2 and genes related to antimicrobial response and immunoregulation. LND cells, confirmed by in-situ RNA and protein imaging, are rare in non-IBD controls but expand in active CD, and actively interact with immune cells and specifically express IBD/CD susceptibility genes, suggesting a possible function in CD immunopathogenesis. Furthermore, we discover early and late LND subpopulations with different origins and developmental potential. A higher ratio of late-to-early LND cells correlates with better response to anti-TNF treatment. Our findings thus suggest a potential pathogenic role for LND cells in both Crohn’s ileitis and colitis.
- 22 August 2024
- Published by Springer Nature in Nature Communications
- Vol. 15 (1) , 1-19
Open AccessIdentification and multimodal characterization of a specialized epithelial cell type associated with Crohn’s disease
Crohn’s disease (CD) is a complex chronic inflammatory disorder with both gastrointestinal and extra-intestinal manifestations associated immune dysregulation. Analyzing 202,359 cells from 170 specimens across 83 patients, we identify a distinct epithelial cell type in both terminal ileum and ascending colon (hereon as ‘LND’) with high expression of LCN2, NOS2, and DUOX2 and genes related to antimicrobial response and immunoregulation. LND cells, confirmed by in-situ RNA and protein imaging, are rare in non-IBD controls but expand in active CD, and actively interact with immune cells and specifically express IBD/CD susceptibility genes, suggesting a possible function in CD immunopathogenesis. Furthermore, we discover early and late LND subpopulations with different origins and developmental potential. A higher ratio of late-to-early LND cells correlates with better response to anti-TNF treatment. Our findings thus suggest a potential pathogenic role for LND cells in both Crohn’s ileitis and colitis.
- Top Cited PapersOpen Access
- 27 February 2024
- Published by Elsevier in Medical Image Analysis
- Vol. 94, 103124
Cross-scale multi-instance learning for pathological image diagnosis
- 27 February 2024
- Published by Elsevier in Medical Image Analysis
- Vol. 94, 103124
Top Cited PapersOpen AccessCross-scale multi-instance learning for pathological image diagnosis
- 6 July 2023
- Published by Elsevier in Gastroenterology
- Vol. 164 (6)
Tu1233 DELETION OF ACONITATE DECARBOXYLASE 1 EXACERBATES EXPERIMENTAL COLITIS AND IS ASSOCIATED WITH A DYSBIOTIC MICROBIOME
- 6 July 2023
- Published by Elsevier in Gastroenterology
- Vol. 164 (6)
Tu1233 DELETION OF ACONITATE DECARBOXYLASE 1 EXACERBATES EXPERIMENTAL COLITIS AND IS ASSOCIATED WITH A DYSBIOTIC MICROBIOME